Can Botulinum Toxin Type A effectively treat neuropathic pain in spinal cord injury?: A protocol of systematic review and meta-analysis

BACKGROUND: This protocol aims to assess the efficacy and safety of Botulinum Toxin Type A (BTTA) for the treatment of neuropathic pain (NPP) in patients with spinal cord injury (SCI). METHODS: We will retrieve databases in Cochrane Library, EMBASE, MEDLINE, Excerpta Medica Database, PsychINFO, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zeng-mian, Wang, Ze-yu, Wei, Chun-jie, Jiang, Yao-jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310841/
https://www.ncbi.nlm.nih.gov/pubmed/32569202
http://dx.doi.org/10.1097/MD.0000000000020702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310841/
https://www.ncbi.nlm.nih.gov/pubmed/32569202
http://dx.doi.org/10.1097/MD.0000000000020702

Ejemplares similares